Showing results (1241-1250 of 1,300) with videos related to

Sort By:
Pageof 130
ACS Chemical Neuroscience|September 15, 2015
Novel Synthesis and Pharmacological Characterization of NOP Receptor Agonist 8-[(1S,3aS)-2,3,3a,4,5,6-Hexahydro-1H-phenalen-1-yl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one (Ro 64-6198)Steven D Chang, Lawrence E Brieaddy, Joseph D Harvey, et al.
British Journal of Cancer|October 4, 2017
A Phase 1 study of ARQ 087, an oral pan-FGFR inhibitor in patients with advanced solid tumoursK P Papadopoulos, B F El-Rayes, A W Tolcher, et al.
Trials|June 22, 2014
Evaluation of a corticotropin releasing hormone type 1 receptor antagonist in women with posttraumatic stress disorder: study protocol for a randomized controlled trialBoadie W Dunlop, Barbara O Rothbaum, Elisabeth B Binder, et al.
Biorxiv : the Preprint Server for Biology|July 28, 2023
Sexually dimorphic differences in angiogenesis markers predict brain aging trajectoriesA Torres-Espin, Hannah Rabadaugh, S Fitzsimons, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 31, 2014
Effects of the D1 dopamine receptor agonist dihydrexidine (DAR-0100A) on working memory in schizotypal personality disorderDaniel R Rosell, Lauren C Zaluda, Margaret M McClure, et al.
Molecular Psychiatry|April 4, 2025
Protein aggregation identified in olfactory neuronal cells is associated with cognitive impairments in a subset of living schizophrenia patientsLeslie G Nucifora, Koko Ishizuka, Nagat El Demerdash, et al.
Communications Biology|December 9, 2022
Bayesian model and selection signature analyses reveal risk factors for canine atopic dermatitisKatarina Tengvall, Elisabeth Sundström, Chao Wang, et al.
Cell Reports|March 22, 2018
Silk Fibroin Films Facilitate Single-Step Targeted Expression of Optogenetic ProteinsSkyler L Jackman, Christopher H Chen, Selmaan N Chettih, et al.
Schizophrenia Research|June 2, 2015
The Management of Schizophrenia in Clinical Practice (MOSAIC) Registry: a focus on patients, caregivers, illness severity, functional status, disease burden and healthcare utilizationHenry A Nasrallah, Philip D Harvey, Daniel Casey, et al.
Schizophrenia Research|October 3, 2015
Improving the understanding of the link between cognition and functional capacity in schizophrenia and bipolar disorderRaeanne C Moore, Alexandrea L Harmell, Philip D Harvey, et al.
Pageof 130